KMT2C and cancer: The H3K4 monomethylase KMT2C is a frequent target of mutations in CRC and other cancer types [1], and studies have demonstrated different effects of different mutations on KMT2C function [22, 39], suggesting the need for further investigation of KMT2C in tumorigenesis.